$ABT

AI Analysis

Generated on May 18, 2026

AI Score
73/ 100
Buy$ABT

Abbott Laboratories

$ABTNYSEHealthcareLarge-Cap

Abbott discovers, develops, manufactures, and sells health care products worldwide in diagnostics, medical devices, nutrition, and pharmaceuticals.

Market Cap
$210B
Revenue (TTM)
$42.5B
+5.8%
Net Income (TTM)
$7.8B
+8.2%
EPS (TTM)
$4.52
P/E Ratio
26.8
Dividend Yield
1.8%
52-Week Range
$102-$128
Beta
0.72
Dimension Scores
Fundamental
76
Technical
70
Sentiment
72
Risk / Reward
74
Momentum
68
FundTechSentRiskMome
Financial Health
Profitability
78moderate
Growth
68moderate
Liquidity
80strong
Solvency
78moderate
Efficiency
76moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $ABT

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.